Testosterone Testing Has Increased in Recent Years

This article originally appeared here.
Share this content:
Testosterone Testing Has Increased in Recent Years
Testosterone Testing Has Increased in Recent Years

(HealthDay News) -- There has been a recent increase in the rate of testosterone testing, with more testing seen in men with comorbidities associated with hypogonadism, according to research published online Nov. 10 in the Journal of Sexual Medicine.

Rena D. Malik, M.D., from the University of Chicago Medical Center, and colleagues examined the testing behaviors of practitioners and characteristics of men who are undergoing testing for low testosterone. Men aged 18 to 85 years were considered tested if they had undergone serum testosterone level testing for any purpose from 2009 to 2012.

The researchers found that 3.2 percent of the 321,674 men underwent testing with a serum total testosterone. During the study period the frequency of testing increased from 2.5 to 3.6 percent (P < 0.001). Tested men were significantly more likely to be Caucasian (P < 0.001) and have increased body mass index, in multivariable analysis, and they were significantly more likely to have comorbid conditions such as decreased libido, infertility, erectile dysfunction, osteoporosis, depression, prostate cancer, hypertension, chronic obstructive pulmonary disease, and benign prostatic hyperplasia. Only 9 percent of tested men underwent testing between 7 a.m. and 12 p.m.

"The rate of testosterone testing is increasing with most testing practices directed toward a subset of men with comorbidities that are associated with hypogonadism," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths